By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TWi Pharmaceuticals, Inc. 

4F, No. 41, Lane 221
Kang Chien Rd.
Nei Hu Dist.  Taipei  114 
Phone: 886-2-26573350 Fax: 886-2-26573391


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
TWi Pharmaceuticals, Inc. Receives Favorable Decision From The U.S. Court Of Appeals For The Federal Circuit Regarding TWi's Generic Version Of MEGACE ES 625mg/5ml 12/16/2015 6:23:43 AM
TWi Pharmaceuticals, Inc. Issues GDR And Raised NT$ 2.83 Billion 9/17/2015 6:45:04 AM
TWi Pharmaceuticals, Inc. President & CEO Ms. Tina Guilder Will Resign From Her Current Roles And Chairman Dr. Chih-Ming Chen Will Become Interim President & CEO, Leading The Company In Its Continued Efforts To Develop High-Entry-Barrier Generics For The U.S. Market 8/31/2015 6:59:55 AM
TWi Pharmaceuticals, Inc. Announces 2Q 2015 Financial Results And EPS For 2Q Of NT$0.69 8/14/2015 6:58:56 AM
TWi Pharmaceuticals, Inc. Release: Twi Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In Europe And Russia 8/3/2015 6:46:30 AM
TWi Pharmaceuticals, Inc. Launches Generic MEGACE ES After Favorable Decision In Patent Suit 7/29/2015 11:29:18 AM
TWi Pharmaceuticals, Inc. Receives U.S. FDA Final Approval On Generic Guanfacine HCl ER Tablet 6/3/2015 9:11:01 AM
TWi Pharmaceuticals, Inc. Announced The Promotion Of R&D EVP Jianbo Xie As COO 5/14/2015 6:40:58 AM
TWi Pharmaceuticals, Inc. Announces Settlement With Takeda (TKPYY) On Dexilant(R) Litigation 4/27/2015 7:01:20 AM
TWi Pharmaceuticals, Inc. USA Announces The Receipt Of State Sales Licenses From All 50 States In The U.S. 4/17/2015 7:36:06 AM
123
//-->